Natco Erlotinib Price India | Erlonat Erlotinib 100mg Tablets

About Erlonat Erlotinib 100mg Tablets

Erlotinib is also known by its brand name, Erlonat . It is a treatment for
• Pancreatic cancer that has spread – alongside the another chemotherapy drug
• Non small cell lung cancer that has spread
image
Brand Name : Erlonat
Active Ingredients : Erlotinib Hydrochloride
Manufactured by: Natco Pharma Ltd.
Strength: 100 mg
Form: Tablets
Packing: Pack of 30 Tablets

What are the possible Side Effects of Erlotinib?


Erlotinib can cause serious side effects, including:
Lung problems : Symptoms of lung problems may include shortness of breath, cough, and fever. Erlotinib may need to be stopped if you have any of these symptoms
Liver and kidney problems. Some people had their kidneys and liver stop working. Speak your doctor know if you have a history of liver or kidney disease
Stomach and intestinal problems (called gastrointestinal [GI] perforation). A GI perforation is a hole that develops in your stomach or intestine.
Serious skin conditions. Erlotinib has been shown to cause blistering and skin peeling. This may result in other serious skin disorders or death
Blood, bleeding, and clotting problems. Erlonat has been shown to cause certain blood problems and other bleeding and clotting problems. These have led to stroke and death.
Eye disorders. It has been shown to cause dry eyes, unusual eyelash growth, or swelling of the cornea. The cornea is the clear coating of the eyeball. This swelling may irritate or damage the eye
Pregnancy. Erlotinib can harm an unborn baby. Tell your doctor if you have become pregnant, or if you think you may be pregnant, during treatment with it. Do not breast-feed during treatment with it.

What should I know about skin (including rash), hair, and nail problems or diarrhea while taking Erlotinib?


Skin (including rash): While taking Erlotinib, rash could happen or get worse if the skin is exposed to the sun. You may want to use alcohol-free lotions and sunscreens or avoid being out in the sun
Your skin and nails may get darker. You may also have dry skin that may or may not crack. This most often happens with rash
Talk with your doctor if you notice a rash. He or she may be able to help you manage it
Hair and nails: Hair and nail problems have been seen in patients taking Erlotinib. These include increased hairiness and brittle or loose nails
Diarrhea: Diarrhea can usually be treated with antidiarrhea medicine. Your Health Care Provider can help you find the right medicine for you

What should I do if I am taking or am prescribed other medicines or supplements while taking Erlotinib?


• Always tell your doctor about all of the medicines and herbal supplements you are taking
• Do not start taking any new medicines or herbal supplements before talking with your doctor
• Do not eat grapefruit or drink grapefruit juice .

Will smoking affect my treatment with Erlotinib?


• If you smoke, you should stop smoking before you start treatment with Erlotinib
• If you continue to smoke, your treatment with Erlotinib may need to be adjusted. Talk with your doctor if you continue to smoke
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

Source:http://www.bagtheweb.com/b/9Oi8l3

Comments

  1. Erlonat 150mg Tablet. is a kinase inhibitor which is primarily used to treat cell lung cancer.Erlonat Tablet works by inhibiting growth to adjacent tissues in the body so that the cancerous cells slow down, allowing the patient a better environment to recover and fight cancer naturally.

    ReplyDelete
  2. this article is very useful for me to know about Erlonat 100mg,Erlonat 100mg tablets details...,
    thank you for sharing this article..,
    Erlonat 100mg
    Erlonat 100mg tablets

    ReplyDelete

Post a Comment

Popular posts from this blog

EMA Recommends Extension of Indications for Ramucirumab

Dr. Hootie Warren takes helm of Fred Hutch Global Oncology

Merck announces positive event-free survival data from phase 3 KEYNOTE-522 study of Keytruda to treat triple-negative breast cancer